Jacalyn Rosenblatt

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Noopur Raje, Jesús G. Berdeja, Yi Lin et al. · New England Journal of Medicine · 2019 · 1.7K citations · Full text

PML targeting eradicates quiescent leukaemia-initiating cells

Keisuke Ito, Rosa Bernardi, Alessandro Morotti et al. · Nature · 2008 · 534 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Medicine +2

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 375 citations · Full text

Hematological Malignancy, Medicine, Hematology +6

BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer

Roxana Moslehi, William Chu, Beth Y. Karlan et al. · The American Journal of Human Genetics · 2000 · 319 citations · Full text

Somatic Variant, Medicine, Pathology +6

PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine

Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills et al. · Journal of Immunotherapy · 2011 · 282 citations

Active Myeloma, Pd-1 Blockade, Immunology +19